Skip to main content
Caplight Logo









Xgenera

Xgenera

Private
SouthamptonAI, Data & Cloud Infrastructurehttps://www.xgenera.com/

Last Round

Seed

Dec 3, 2024

Total Funding Raised

$7.75M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Xgenera is a biotechnology company that develops multi-cancer early detection (MCED) diagnostic tests using microRNA biomarkers and machine learning.

Sector

AI, Data & Cloud Infrastructure

Verticals

Cloud Infrastructure, DevOps & Containers

Business Model

B2G

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Application

Keywords

cancer diagnosticsliquid biopsyAI diagnosticsmicroRNA analysisbiotech startupmulti-cancer detectionclinical validationhealthtechdiagnostic testprecision medicinebiomarker discoveryAI in healthcaremedical AIgenomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Xgenera Comparables

Compare Xgenera with similar companies based on industry and business-model similarity.

No public comparables are available for Xgenera. Request access to learn about comparables coverage.

Request access

Xgenera Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 3, 2024
GrantSep 1, 2024

Key People

Founding team and executive leadership

Andy Shapanis

Chief Executive Officer

Executive Team

Xgenera Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 3162% MoM, from 42 to 1.4K.

  • Jan 10, 2025

    Grew 100% QoQ, from 4 to 8 employees.

Xgenera Filings

Explore SEC and related filing metadata, where available.

Xgenera filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Xgenera's valuation, stock price, and market status.

Is Xgenera a public or private company?

Xgenera is a private company.

What is the current stock price of Xgenera?

Xgenera is a private company with no public stock price. No recent secondary market data is available.

How much is Xgenera worth (valuation)?

Valuation information for Xgenera is not publicly available.

Can I buy Xgenera stock?

Xgenera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Xgenera's last funding round?

Xgenera's most recent funding round was Seed on December 3, 2024.

Who are the main investors in Xgenera?

Key investors in Xgenera include QantX.

Will Xgenera IPO soon?

No public IPO plans have been announced for Xgenera.

How can I track Xgenera secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Xgenera's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSouthampton
Employee Range6
Year Founded2023
Last FundingDec 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?